Skip to Content

45 Results Found

  • Article
  • Open Access
583 Views
8 Pages

25 June 2026

While minimalist kinetic models effectively capture the acute inverse coupling between Hepatitis B (HBV) and Hepatitis Delta (HDV), they often fail to account for the asymptotic stability and long-term viral plateaus observed during clinical therapy....

(This article belongs to the Section General Virology)
  • Review
  • Open Access
9 Citations
4,457 Views
17 Pages

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?

  • Giovana Paula Angelice,
  • Pedro Henrique Roque,
  • Gabriel Valente,
  • Krishna Galvão and ,
  • Livia Melo Villar,
  • Vinicius Motta Mello,
  • Francisco C. A. Mello and
  • Bárbara Vieira Lago
  • + 3 authors+ 0 author

31 October 2024

Background: Despite an existing safe and effective vaccine for hepatitis B virus (HBV), it is still a major public health concern. Nowadays, several drugs are used to treat chronic hepatitis B; however, full healing remains controversial. The viral c...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
30 Citations
12,144 Views
30 Pages

Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability

  • Marina Campos-Valdez,
  • Hugo C. Monroy-Ramírez,
  • Juan Armendáriz-Borunda and
  • Laura V. Sánchez-Orozco

18 June 2021

The immunopathogenesis and molecular mechanisms involved during a hepatitis B virus (HBV) infection have made the approaches for research complex, especially concerning the patients’ responses in the course of the early acute stage. The study of mole...

(This article belongs to the Special Issue Structural Variations and Molecular Genetics of Hepatitis Virus and Related Viruses)
  • Commentary
  • Open Access
2 Citations
1,425 Views
14 Pages

Virological Insights from ARC-520 siRNA and Entecavir Treated Chronically HBV-Infected Patients and Chimpanzees

  • Christine I. Wooddell,
  • Lung Yi Mak,
  • Wai-Kay Seto,
  • Bruce D. Given and
  • Man-Fung Yuen

In a previous study, eight chronically HBV-infected nucleos (t)ide analog (NA)-naïve patients began receiving entecavir (ETV) concomitant with a single ARC-520 HBV siRNA injection. This single dose of ARC-520 (SD) was followed by 6–8 month...

(This article belongs to the Special Issue Diagnosis, Treatment and Prevention of Viral Infections)
  • Article
  • Open Access
5 Citations
3,247 Views
32 Pages

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA

  • Christine I. Wooddell,
  • Dean Sanders,
  • Zhao Xu,
  • Lung-Yi Mak and ,
  • Thomas Schluep,
  • Wai-Kay Seto,
  • Bruce D. Given and
  • Man-Fung Yuen
  • + 3 authors+ 0 author

19 December 2024

Full-length hepatitis B virus (HBV) transcripts of chimpanzees and patients treated with multidose (MD) HBV siRNA ARC-520 and entecavir (ETV) were characterized by single-molecule real-time (SMRT) sequencing, identifying multiple types of transcripts...

(This article belongs to the Special Issue HBV Transcriptional and Post-transcriptional Regulation)
  • Review
  • Open Access
55 Citations
13,828 Views
22 Pages

18 August 2017

Hepatitis B virus (HBV) causes liver diseases that have been a consistent problem for human health, leading to more than one million deaths every year worldwide. A large proportion of hepatocellular carcinoma (HCC) cases across the world are closely...

(This article belongs to the Special Issue Viral Infection and Apoptosis)
  • Review
  • Open Access
34 Citations
14,083 Views
14 Pages

7 November 2013

The hepatitis B virus (HBV) is a small enveloped DNA virus that belongs to the Hepadnaviridae family. HBV can cause acute and persistent infection which can lead to hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) play a crucial role in the main ce...

(This article belongs to the Special Issue Viruses and miRNAs)
  • Review
  • Open Access
2 Citations
4,868 Views
15 Pages

22 July 2022

The liver is unique in its ability to regenerate in response to damage. The complex process of liver regeneration consists of multiple interactive pathways. About 2 billion people worldwide have been infected with hepatitis B virus (HBV), and HBV cau...

(This article belongs to the Section Infectious Agents and Cancer)
  • Review
  • Open Access
38 Citations
13,044 Views
22 Pages

Progress and Prospects of Anti-HBV Gene Therapy Development

  • Mohube B. Maepa,
  • Ilke Roelofse,
  • Abdullah Ely and
  • Patrick Arbuthnot

31 July 2015

Despite the availability of an effective vaccine against hepatitis B virus (HBV), chronic infection with the virus remains a major global health concern. Current drugs against HBV infection are limited by emergence of resistance and rarely achieve co...

(This article belongs to the Special Issue Viral Hepatitis Research)
  • Review
  • Open Access
24 Citations
5,980 Views
25 Pages

Gene-Editing and RNA Interference in Treating Hepatitis B: A Review

  • Nadiia Kasianchuk,
  • Krystyna Dobrowolska,
  • Sofiia Harkava,
  • Andreea Bretcan and ,
  • Dorota Zarębska-Michaluk,
  • Jerzy Jaroszewicz,
  • Robert Flisiak and
  • Piotr Rzymski
  • + 3 authors+ 0 author

8 December 2023

The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatmen...

(This article belongs to the Special Issue Recent Advances in Anti-HCV, Anti-HBV and Anti-flavivirus Agents)
  • Review
  • Open Access
44 Citations
17,843 Views
14 Pages

4 January 2025

Hepatitis B virus (HBV) is a major global health issue, with an estimated 254 million people living with chronic HBV infection worldwide as of 2022. Chronic HBV infection is the leading cause of cirrhosis and liver cancer. Current treatment with nucl...

(This article belongs to the Special Issue Molecular Mechanisms Underlying Liver Diseases)
  • Article
  • Open Access
26 Citations
6,229 Views
12 Pages

18 March 2022

In chronic hepatitis B virus (HBV) infection, virus-specific T cells are scarce and partially dysfunctional. Therapeutic vaccination is a promising strategy to induce and activate new virus-specific T cells. In long-term or high-level HBV carriers, h...

(This article belongs to the Topic Novel Biomolecules Modulating Innate Immune Responses against Virus Infection)
  • Article
  • Open Access
5 Citations
3,166 Views
16 Pages

HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression

  • Matthieu Blanchet,
  • Léna Angelo,
  • Yasmine Tétreault,
  • Marwa Khabir and ,
  • Camille Sureau,
  • Andrew Vaillant and
  • Patrick Labonté
  • + 2 authors+ 0 author

29 March 2024

Individuals chronically infected with hepatitis B virus (HBV) and hepatitis Delta virus (HDV) present an increased risk of developing cirrhosis and hepatocellular carcinoma in comparison to HBV mono-infected individuals. Although HDV only replicates...

(This article belongs to the Special Issue Life Cycle of Hepatitis D Virus (HDV) and HDV-Like Agents)
  • Review
  • Open Access
19 Citations
11,767 Views
36 Pages

Functional Cure for Hepatitis B Virus: Challenges and Achievements

  • Oren Shechter,
  • Daniel G. Sausen,
  • Harel Dahari,
  • Andrew Vaillant and ,
  • Scott J. Cotler and
  • Ronen Borenstein
  • + 1 author+ 0 author

The Hepatitis B Virus (HBV) presents a formidable global health challenge, impacting hundreds of millions worldwide and imposing a considerable burden on healthcare systems. The elusive nature of the virus, with its ability to establish chronic infec...

(This article belongs to the Special Issue Liver Diseases: From Molecular Basis to Potential Therapy)
  • Article
  • Open Access
12 Citations
3,082 Views
16 Pages

Immunoinformatics and Evaluation of Peptide Vaccines Derived from Global Hepatitis B Viral HBx and HBc Proteins Critical for Covalently Closed Circular DNA Integrity

  • Umar Saeed,
  • Zahra Zahid Piracha,
  • Salman Alrokayan,
  • Tajamul Hussain and ,
  • Fahad N. Almajhdi and
  • Yasir Waheed
  • + 1 author+ 0 author

The Hepatitis B virus (HBV) HBx and HBc proteins play a crucial role in associating with covalently closed circular DNA (cccDNA), the primary factor contributing to intrahepatic viral persistence and a major obstacle in achieving a cure for HBV. The...

(This article belongs to the Special Issue Control and Elimination of Viral Hepatitis)
  • Review
  • Open Access
66 Citations
9,595 Views
20 Pages

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection

  • Fiona van den Berg,
  • Shonisani Wendy Limani,
  • Njabulo Mnyandu,
  • Mohube Betty Maepa and ,
  • Abdullah Ely and
  • Patrick Arbuthnot
  • + 1 author+ 0 author

4 August 2020

Infection with hepatitis B virus (HBV) remains a global health challenge. Approximately 292 million people worldwide are chronically infected with HBV and the annual mortality from the infection is approaching 900,000. Despite the availability of an...

(This article belongs to the Special Issue RNA Interference (RNAi) for Antiviral Therapy)
  • Review
  • Open Access
26 Citations
6,674 Views
11 Pages

Prospects for Controlling Hepatitis B Globally

  • Vicente Soriano,
  • Víctor Moreno-Torres,
  • Ana Treviño,
  • Fernando de Jesús and ,
  • Octavio Corral and
  • Carmen de Mendoza
  • + 1 author+ 0 author

Infection with the hepatitis B virus (HBV) is highly prevalent globally. Over 250 million people suffer from chronic hepatitis B, and more than 800,000 patients die each year due to hepatitis B complications, including liver cancer. Although protecti...

(This article belongs to the Special Issue Viral Infections of Humans: Epidemiology and Control)
  • Article
  • Open Access
17 Citations
7,329 Views
21 Pages

21 June 2017

Many viruses take advantage of cellular trafficking machineries to assemble and release new infectious particles. Using RNA interference (RNAi), we demonstrate that the Golgi/autophagosome-associated Rab33B is required for hepatitis B virus (HBV) pro...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
1 Citations
1,760 Views
20 Pages

Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus Replication

  • Collins Oduor Owino,
  • Balakrishnan Chakrapani Narmada,
  • Gian Yi Lin,
  • Pauline Poh Kim Aw and ,
  • Nivrithi Ganesh,
  • Jovi Tan Siying,
  • Marie-Laure Plissonnier,
  • Thangavelu Thangavelu Matan,
  • Niranjan Shirgaonkar and
  • Ramanuj DasGupta
  • + 9 authors+ 4 authors

8 May 2026

Background and Aims: Understanding regulatory interactions between hepatitis B virus (HBV) and host factors is essential for the development of next generation host-directed antiviral therapies and the achievement of a functional HBV cure. Here, we i...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Feature Paper
  • Review
  • Open Access
42 Citations
18,833 Views
27 Pages

Recent Advances in Hepatitis B Treatment

  • Georgia-Myrto Prifti,
  • Dimitrios Moianos,
  • Erofili Giannakopoulou,
  • Vasiliki Pardali and ,
  • John E. Tavis and
  • Grigoris Zoidis
  • + 1 author+ 0 author

Hepatitis B virus infection affects over 250 million chronic carriers, causing more than 800,000 deaths annually, although a safe and effective vaccine is available. Currently used antiviral agents, pegylated interferon and nucleos(t)ide analogues, h...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
135 Citations
16,493 Views
23 Pages

21 February 2022

With 296 million cases estimated worldwide, chronic hepatitis B virus (HBV) infection is the most common risk factor for hepatocellular carcinoma (HCC). HBV-encoded oncogene X protein (HBx), a key multifunctional regulatory protein, drives viral repl...

(This article belongs to the Special Issue Molecular Mechanisms of Hepatocellular Carcinoma)
  • Review
  • Open Access
1,950 Views
16 Pages

12 September 2025

Nucleic acid-based gene-interfering molecules, such as antisense oligonucleotides, ribozymes, and small interfering RNA (siRNA), represent exciting gene-targeting agents for therapeutic applications. RNase P ribozymes derived from M1 RNA, the catalyt...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
8 Citations
5,079 Views
23 Pages

Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence Conservation

  • Eva Dopico,
  • Marta Vila,
  • David Tabernero,
  • Josep Gregori and ,
  • Ariadna Rando-Segura,
  • Beatriz Pacín-Ruíz,
  • Laura Guerrero,
  • Itziar Ubillos,
  • Miguel J. Martínez and
  • Maria Francesca Cortese
  • + 15 authors+ 10 authors

Our aim was to develop an accurate, highly sensitive method for HBV genotype determination and detection of genotype mixtures. We examined the preS and 5′ end of the HBV X gene (5X) regions of the HBV genome using next-generation sequencing (NG...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
2 Citations
5,534 Views
12 Pages

Histopathological Features of Hepatocellular Carcinoma in Patients with Hepatitis B and D Virus Infection: A Single-Institution Study in Mongolia

  • Orgil Jargalsaikhan,
  • Wenhua Shao,
  • Mayuko Ichimura-Shimizu,
  • Soichiro Ishimaru and ,
  • Takaaki Koma,
  • Masako Nomaguchi,
  • Hirohisa Ogawa,
  • Shotaro Tachibana,
  • Battogtokh Chimeddorj and
  • Koichi Tsuneyama
  • + 15 authors+ 10 authors

27 January 2025

Background: Viral hepatitis, particularly hepatitis B (HBV) and hepatitis C (HCV), is highly prevalent in Mongolia. Moreover, Mongolia has the highest prevalence of hepatitis delta virus (HDV) globally, with over 60% of HBV-infected individuals also...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
10 Citations
4,299 Views
13 Pages

Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors

  • Michael Kirstgen,
  • Kira Alessandra Alicia Theresa Lowjaga,
  • Simon Franz Müller,
  • Nora Goldmann and ,
  • Felix Lehmann,
  • Dieter Glebe,
  • Karl-Heinz Baringhaus and
  • Joachim Geyer
  • + 3 authors+ 0 author

12 April 2021

Identification of Na+/taurocholate co-transporting polypeptide (NTCP) as high-affinity hepatic entry receptor for the Hepatitis B and D viruses (HBV/HDV) opened the field for target-based development of cell-entry inhibitors. However, most of the HBV...

(This article belongs to the Section Animal Viruses)
  • Review
  • Open Access
71 Citations
12,790 Views
15 Pages

Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?

  • Kristie Bloom,
  • Mohube Betty Maepa,
  • Abdullah Ely and
  • Patrick Arbuthnot

12 April 2018

Chronic infection with the hepatitis B virus (HBV) is a global health concern and accounts for approximately 1 million deaths annually. Amongst other limitations of current anti-HBV treatment, failure to eliminate the viral covalently closed circular...

(This article belongs to the Special Issue Hepatitis B Virus Infection: An Update on Epidemiology, Diagnosis, Treatment and Prevention)
  • Article
  • Open Access
1 Citations
2,075 Views
14 Pages

Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania

  • Mohamed Abdawa,
  • Mohamed Hemeyine,
  • Isabelle Chemin,
  • Françoise Lunel-Fabiani and
  • Mohamed Vall Mohamed Abdellahi

12 February 2026

Background: Hepatitis B virus (HBV) infection remains highly endemic in sub-Saharan Africa, where hepatitis delta virus (HDV) co-infection substantially worsens liver disease outcomes. Mauritania has long been suspected to be a high-burden setting fo...

(This article belongs to the Section Infectious Disease)
  • Review
  • Open Access
37 Citations
7,023 Views
16 Pages

18 June 2021

Globally, chronic hepatitis B (CHB) infection is one of the leading causes of liver failure, decompensated cirrhosis, and hepatocellular carcinoma. Existing antiviral therapy can suppress viral replication but not fully eradicate the virus nor the ri...

(This article belongs to the Special Issue Recent Advances in Management of Hepatitis B and towards Achieving a HBV Cure)
  • Article
  • Open Access
5 Citations
3,341 Views
12 Pages

Hepatitis B Immunization Status in Children with Chronic Kidney Disease: Experience at a Single Center, Egypt

  • Doaa Mohammed Youssef,
  • Amal S. El-Shal,
  • Rabab M. Elbehidy,
  • Mohamed Adel Fouda and ,
  • Sally M. Shalaby,
  • Lamiaa Lotfy El Hawy,
  • Abdelrahman Fathi Elsadek,
  • Mayy Abd Alfattah Neemat-Allah,
  • Seham M. Ramadan and
  • Mona Hamed Gehad
  • + 11 authors+ 6 authors

27 February 2023

Background: Children with chronic kidney disease (CKD), particularly those who require hemodialysis (HD), are at high risk of hepatitis B virus (HBV) infection. The HBV vaccine non-/hypo-response rate among HD children remains high, and it is critica...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
2 Citations
1,892 Views
13 Pages

17 October 2025

Fluorescence anisotropy (FA) has been widely used for analyzing biomolecules due to its high throughput, homogeneous detection, and strong resistance to photobleaching. However, the traditional FA method suffers from low sensitivity when the target m...

(This article belongs to the Special Issue State-of-the-Art Biosensors in China (2nd Edition))
  • Article
  • Open Access
2,857 Views
18 Pages

Available interventions for the management of chronic hepatitis B (hepB) exhibit limited efficacy and barriers to vaccination against the hepatitis B virus (HBV) have hampered prophylaxis programmes. Development of potent therapeutics capable of func...

(This article belongs to the Section Medical Microbiology)
  • Review
  • Open Access
25 Citations
5,515 Views
21 Pages

30 March 2021

Chronic hepatitis B infection remains a globally important cause of morbidity and mortality and has recently undergone a renaissance in therapeutic interest with increased pre-clinical and clinical testing of new drug classes. One of the first new cl...

(This article belongs to the Special Issue Viral Integration)
  • Article
  • Open Access
23 Citations
4,668 Views
20 Pages

26 March 2021

The hepatitis B virus (HBV) capsid is an attractive drug target, relevant to combating viral hepatitis as a major public health concern. Among small molecules known to interfere with capsid assembly, the phenylpropenamides, including AT130, represent...

(This article belongs to the Special Issue Capsid-Targeting Antivirals and Host Factors)
  • Review
  • Open Access
19 Citations
5,854 Views
26 Pages

Deciphering Host–Virus Interactions and Advancing Therapeutics for Chronic Viral Infection

  • Majid Eslami,
  • Neda Arjmand,
  • Fatemeh Mahmoudian,
  • Ali Babaeizad and ,
  • Hamed Tahmasebi,
  • Fahimeh Fattahi and
  • Valentyn Oksenych
  • + 2 authors+ 0 author

10 March 2025

Chronic viral infections like HIV, HBV, and HCV establish persistent interactions with the host immune system, resulting in immune evasion and long-term immune dysfunction. These viruses use a range of strategies to limit host defenses, such as downr...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
1 Citations
2,518 Views
14 Pages

New Advances in Small Molecules Targeted at Viral Capsid–Genome Binding

  • Jiamei Li,
  • Chengfeng Zhang,
  • Benteng Li and
  • Yuqing Wu

The capsid protein plays a crucial role in the viral life cycle. By interacting with the viral genome, it facilitates the assembly of the nucleocapsid, ultimately leading to the formation of the viral particle. Therefore, interfering with or disrupti...

(This article belongs to the Special Issue Latest Review Papers in Macromolecules 2025)
  • Review
  • Open Access
89 Citations
9,460 Views
25 Pages

22 April 2022

Viruses have been a long-term source of infectious diseases that can lead to large-scale infections and massive deaths. Especially with the recent highly contagious coronavirus (COVID-19), antiviral drugs were developed nonstop to deal with the emerg...

(This article belongs to the Special Issue Synthesis of Heteroaromatic Compounds)
  • Review
  • Open Access
26 Citations
8,670 Views
14 Pages

RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects

  • Laura Sneller,
  • Christine Lin,
  • Angie Price,
  • Shyam Kottilil and
  • Joel V. Chua

Chronic hepatitis B (CHB) is a global health challenge that can result in significant liver-related morbidity and mortality. Despite a prophylactic vaccine being available, patients already living with CHB often must engage in lifelong therapy with n...

(This article belongs to the Section Virology)
  • Article
  • Open Access
8 Citations
3,962 Views
11 Pages

An Advanced, Silicon-Based Substrate for Sensitive Nucleic Acids Detection

  • Salvatore Petralia,
  • Nunzio Vicario,
  • Giovanna Calabrese,
  • Rosalba Parenti and
  • Sabrina Conoci

17 September 2018

Surface substrate and chemical functionalization are crucial aspects for the fabrication of the sensitive biosensor based on microarray technology. In this paper, an advanced, silicon-based substrate (A-MA) allowing enhancement of optical signal for...

(This article belongs to the Section Chemical Sensors)
  • Editorial
  • Open Access
19 Citations
4,604 Views
6 Pages

20 October 2020

RNA interference (RNAi) represents a novel approach for alternative antiviral therapy. However, issues related to RNA delivery and stability have presented serious obstacles for obtaining good therapeutic efficacy. Viral vectors are capable of effici...

(This article belongs to the Special Issue RNA Interference (RNAi) for Antiviral Therapy)
  • Review
  • Open Access
125 Citations
13,560 Views
30 Pages

Aptamers in Diagnostics and Treatment of Viral Infections

  • Tomasz Wandtke,
  • Joanna Woźniak and
  • Piotr Kopiński

16 February 2015

Aptamers are in vitro selected DNA or RNA molecules that are capable of binding a wide range of nucleic and non-nucleic acid molecules with high affinity and specificity. They have been conducted through the process known as SELEX (Systematic Evoluti...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
6 Citations
5,244 Views
24 Pages

10 October 2025

Chronic hepatitis B (CHB) remains a major global health challenge, largely due to the persistence of covalently closed circular DNA (cccDNA) and impaired host immunity. Interferon-α (IFN-α), a key antiviral cytokine, not only directly res...

(This article belongs to the Special Issue Cellular Immune Response to Hepatitis Viruses)
  • Review
  • Open Access
6 Citations
5,839 Views
22 Pages

Vaccine Responses in Patients with Liver Cirrhosis: From the Immune System to the Gut Microbiota

  • Carlo Airola,
  • Silvia Andaloro,
  • Antonio Gasbarrini and
  • Francesca Romana Ponziani

23 March 2024

Vaccines prevent a significant number of deaths annually. However, certain populations do not respond adequately to vaccination due to impaired immune systems. Cirrhosis, a condition marked by a profound disruption of immunity, impairs the normal imm...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Article
  • Open Access
6 Citations
3,727 Views
24 Pages

The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA

  • Yuhang Shi,
  • Sydney Simpson,
  • Shahad K. Ahmed,
  • Yuexuan Chen and ,
  • Aidin Tavakoli-Tameh,
  • Sanath Kumar Janaka,
  • David T. Evans and
  • Ruth Serra-Moreno
  • + 3 authors+ 0 author

20 September 2023

SERINC5 is a restriction factor that becomes incorporated into nascent retroviral particles, impairing their ability to infect target cells. In turn, retroviruses have evolved countermeasures against SERINC5. For instance, the primate lentiviruses (H...

(This article belongs to the Section General Virology)
  • Review
  • Open Access
12 Citations
4,973 Views
21 Pages

Virus-Induced Tumorigenesis and IFN System

  • Marco Iuliano,
  • Giorgio Mangino,
  • Maria Vincenza Chiantore,
  • Paola Di Bonito and ,
  • Paolo Rosa,
  • Elisabetta Affabris and
  • Giovanna Romeo
  • + 2 authors+ 0 author

1 October 2021

Oncogenic viruses favor the development of tumors in mammals by persistent infection and specific cellular pathways modifications by deregulating cell proliferation and inhibiting apoptosis. They counteract the cellular antiviral defense through vira...

  • Article
  • Open Access
1 Citations
2,409 Views
13 Pages

Gene Expression Aberrations in Alcohol-Associated Hepatocellular Carcinoma

  • Andreja Petrović,
  • Paula Štancl,
  • Paula Gršković,
  • Suzana Hančić and ,
  • Rosa Karlić,
  • Slavko Gašparov and
  • Petra Korać
  • + 2 authors+ 0 author

30 September 2024

Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, ranking as the sixth most common cancer worldwide and the fourth leading cause of cancer-related deaths. Most HCC cases originate from cirrhotic livers, typically due to chron...

(This article belongs to the Special Issue Molecular Diagnostics and Genomics of Tumors)